The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Equol ,a metabolite of soybeans, is an important isoflavone in humans，specifically binds to 5α-DHT, has a modest affinity for recombinant estrogen receptor ERβ. Equol is a metabolite produced from the soy phytoestrogen daidzein by the action of gut microflora. Equol has higher affinity for both ERs (estrogen receptors including ERalpha and ERbeta). Equol exists as the enantiomers R-equol and S-equol. S-equol has a high binding affinity, preferential for ERbeta with a Ki of 16 nM whereas R-equol binds more weakly and with a preference for ERalpha K with a Ki of 50 nM. Equol is superior to all other isoflavones in its antioxidant activity. Equol has antioestrogenic properties. Equol is a 100-fold more potent than daidzein in stimulating an oestrogenic response. Equol is also more effective than daidzein in competing with 3 H-oestradiol for binding to the ER. Equol stimulates the growth of MCF-7 cells in a concentration-dependent manner. Although equol exhibits oestrogenic activity, exposure of MCF-7 cells to equol simultaneously with oestradiol is effective in reducing pS2 mRNA expression. Equol results in the downregulation of ER mRNA expression.
The global Equols market was valued at US$ 331 million in 2023 and is anticipated to reach US$ 516.5 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
Equol, a compound produced by certain individuals’ gut bacteria, has gained interest for its potential health benefits, particularly in hormone regulation and cardiovascular health. While equol is not widely available as a standalone product, there has been research exploring its potential use in dietary supplements and functional foods.
The global equol market is still emerging, and its size and growth potential can be influenced by various factors such as consumer awareness, regulatory frameworks, research advancements, and industry collaborations. The market’s development may also be dependent on the availability and commercialization of equol-producing probiotics or other technologies that enhance equol production.
As interest in personalized nutrition and gut health continues to rise, it is conceivable that the equol market may experience growth in the future.
This report aims to provide a comprehensive presentation of the global market for Equols, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equols.
Report Scope
The Equols market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equols market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equols manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tocris Bioscience
Cayman Chemical
Selleck Chemicals
Merck
Santa Cruz Biotechnology, Inc.
Dr Tobias
Otsuka
TCI Chemicals
LKT Laboratories
AdooQ BioScience
Segment by Type
(S)-equol
(R)-equol
Segment by Application
Producing Bacteria
Anti-aging Supplements
Skin Health
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equols manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Equols by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Equols in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Equol ,a metabolite of soybeans, is an important isoflavone in humans，specifically binds to 5α-DHT, has a modest affinity for recombinant estrogen receptor ERβ. Equol is a metabolite produced from the soy phytoestrogen daidzein by the action of gut microflora. Equol has higher affinity for both ERs (estrogen receptors including ERalpha and ERbeta). Equol exists as the enantiomers R-equol and S-equol. S-equol has a high binding affinity, preferential for ERbeta with a Ki of 16 nM whereas R-equol binds more weakly and with a preference for ERalpha K with a Ki of 50 nM. Equol is superior to all other isoflavones in its antioxidant activity. Equol has antioestrogenic properties. Equol is a 100-fold more potent than daidzein in stimulating an oestrogenic response. Equol is also more effective than daidzein in competing with 3 H-oestradiol for binding to the ER. Equol stimulates the growth of MCF-7 cells in a concentration-dependent manner. Although equol exhibits oestrogenic activity, exposure of MCF-7 cells to equol simultaneously with oestradiol is effective in reducing pS2 mRNA expression. Equol results in the downregulation of ER mRNA expression.
The global Equols market was valued at US$ 331 million in 2023 and is anticipated to reach US$ 516.5 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
Equol, a compound produced by certain individuals’ gut bacteria, has gained interest for its potential health benefits, particularly in hormone regulation and cardiovascular health. While equol is not widely available as a standalone product, there has been research exploring its potential use in dietary supplements and functional foods.
The global equol market is still emerging, and its size and growth potential can be influenced by various factors such as consumer awareness, regulatory frameworks, research advancements, and industry collaborations. The market’s development may also be dependent on the availability and commercialization of equol-producing probiotics or other technologies that enhance equol production.
As interest in personalized nutrition and gut health continues to rise, it is conceivable that the equol market may experience growth in the future.
This report aims to provide a comprehensive presentation of the global market for Equols, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equols.
Report Scope
The Equols market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equols market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equols manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tocris Bioscience
Cayman Chemical
Selleck Chemicals
Merck
Santa Cruz Biotechnology, Inc.
Dr Tobias
Otsuka
TCI Chemicals
LKT Laboratories
AdooQ BioScience
Segment by Type
(S)-equol
(R)-equol
Segment by Application
Producing Bacteria
Anti-aging Supplements
Skin Health
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equols manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Equols by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Equols in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Equols Market Overview
1.1 Product Definition
1.2 Equols Segment by Type
1.2.1 Global Equols Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 (S)-equol
1.2.3 (R)-equol
1.3 Equols Segment by Application
1.3.1 Global Equols Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Producing Bacteria
1.3.3 Anti-aging Supplements
1.3.4 Skin Health
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Equols Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Equols Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Equols Production Estimates and Forecasts (2019-2030)
1.4.4 Global Equols Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Equols Production Market Share by Manufacturers (2019-2024)
2.2 Global Equols Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Equols, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Equols Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Equols Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Equols, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Equols, Product Offered and Application
2.8 Global Key Manufacturers of Equols, Date of Enter into This Industry
2.9 Equols Market Competitive Situation and Trends
2.9.1 Equols Market Concentration Rate
2.9.2 Global 5 and 10 Largest Equols Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Equols Production by Region
3.1 Global Equols Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Equols Production Value by Region (2019-2030)
3.2.1 Global Equols Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Equols by Region (2025-2030)
3.3 Global Equols Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Equols Production by Region (2019-2030)
3.4.1 Global Equols Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Equols by Region (2025-2030)
3.5 Global Equols Market Price Analysis by Region (2019-2024)
3.6 Global Equols Production and Value, Year-over-Year Growth
3.6.1 North America Equols Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Equols Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Equols Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Equols Production Value Estimates and Forecasts (2019-2030)
4 Equols Consumption by Region
4.1 Global Equols Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Equols Consumption by Region (2019-2030)
4.2.1 Global Equols Consumption by Region (2019-2024)
4.2.2 Global Equols Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Equols Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Equols Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Equols Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Equols Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Equols Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Equols Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Equols Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Equols Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Equols Production by Type (2019-2030)
5.1.1 Global Equols Production by Type (2019-2024)
5.1.2 Global Equols Production by Type (2025-2030)
5.1.3 Global Equols Production Market Share by Type (2019-2030)
5.2 Global Equols Production Value by Type (2019-2030)
5.2.1 Global Equols Production Value by Type (2019-2024)
5.2.2 Global Equols Production Value by Type (2025-2030)
5.2.3 Global Equols Production Value Market Share by Type (2019-2030)
5.3 Global Equols Price by Type (2019-2030)
6 Segment by Application
6.1 Global Equols Production by Application (2019-2030)
6.1.1 Global Equols Production by Application (2019-2024)
6.1.2 Global Equols Production by Application (2025-2030)
6.1.3 Global Equols Production Market Share by Application (2019-2030)
6.2 Global Equols Production Value by Application (2019-2030)
6.2.1 Global Equols Production Value by Application (2019-2024)
6.2.2 Global Equols Production Value by Application (2025-2030)
6.2.3 Global Equols Production Value Market Share by Application (2019-2030)
6.3 Global Equols Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Tocris Bioscience
7.1.1 Tocris Bioscience Equols Corporation Information
7.1.2 Tocris Bioscience Equols Product Portfolio
7.1.3 Tocris Bioscience Equols Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Tocris Bioscience Main Business and Markets Served
7.1.5 Tocris Bioscience Recent Developments/Updates
7.2 Cayman Chemical
7.2.1 Cayman Chemical Equols Corporation Information
7.2.2 Cayman Chemical Equols Product Portfolio
7.2.3 Cayman Chemical Equols Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Cayman Chemical Main Business and Markets Served
7.2.5 Cayman Chemical Recent Developments/Updates
7.3 Selleck Chemicals
7.3.1 Selleck Chemicals Equols Corporation Information
7.3.2 Selleck Chemicals Equols Product Portfolio
7.3.3 Selleck Chemicals Equols Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Selleck Chemicals Main Business and Markets Served
7.3.5 Selleck Chemicals Recent Developments/Updates
7.4 Merck
7.4.1 Merck Equols Corporation Information
7.4.2 Merck Equols Product Portfolio
7.4.3 Merck Equols Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Merck Main Business and Markets Served
7.4.5 Merck Recent Developments/Updates
7.5 Santa Cruz Biotechnology, Inc.
7.5.1 Santa Cruz Biotechnology, Inc. Equols Corporation Information
7.5.2 Santa Cruz Biotechnology, Inc. Equols Product Portfolio
7.5.3 Santa Cruz Biotechnology, Inc. Equols Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Santa Cruz Biotechnology, Inc. Main Business and Markets Served
7.5.5 Santa Cruz Biotechnology, Inc. Recent Developments/Updates
7.6 Dr Tobias
7.6.1 Dr Tobias Equols Corporation Information
7.6.2 Dr Tobias Equols Product Portfolio
7.6.3 Dr Tobias Equols Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Dr Tobias Main Business and Markets Served
7.6.5 Dr Tobias Recent Developments/Updates
7.7 Otsuka
7.7.1 Otsuka Equols Corporation Information
7.7.2 Otsuka Equols Product Portfolio
7.7.3 Otsuka Equols Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Otsuka Main Business and Markets Served
7.7.5 Otsuka Recent Developments/Updates
7.8 TCI Chemicals
7.8.1 TCI Chemicals Equols Corporation Information
7.8.2 TCI Chemicals Equols Product Portfolio
7.8.3 TCI Chemicals Equols Production, Value, Price and Gross Margin (2019-2024)
7.8.4 TCI Chemicals Main Business and Markets Served
7.7.5 TCI Chemicals Recent Developments/Updates
7.9 LKT Laboratories
7.9.1 LKT Laboratories Equols Corporation Information
7.9.2 LKT Laboratories Equols Product Portfolio
7.9.3 LKT Laboratories Equols Production, Value, Price and Gross Margin (2019-2024)
7.9.4 LKT Laboratories Main Business and Markets Served
7.9.5 LKT Laboratories Recent Developments/Updates
7.10 AdooQ BioScience
7.10.1 AdooQ BioScience Equols Corporation Information
7.10.2 AdooQ BioScience Equols Product Portfolio
7.10.3 AdooQ BioScience Equols Production, Value, Price and Gross Margin (2019-2024)
7.10.4 AdooQ BioScience Main Business and Markets Served
7.10.5 AdooQ BioScience Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Equols Industry Chain Analysis
8.2 Equols Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Equols Production Mode & Process
8.4 Equols Sales and Marketing
8.4.1 Equols Sales Channels
8.4.2 Equols Distributors
8.5 Equols Customers
9 Equols Market Dynamics
9.1 Equols Industry Trends
9.2 Equols Market Drivers
9.3 Equols Market Challenges
9.4 Equols Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
